Literature DB >> 10622676

Evolving standards in patient and caregiver support.

R J Ham1.   

Abstract

It has become increasingly clear that family members and others have enormous potential to contribute positively to the care of the patient suffering from Alzheimer disease (AD). Various methods such as respite services and day care as well as counseling and support groups have been shown to reduce caregiver stress and burnout. Moreover, there are many areas in which the informed, trained caregiver can contribute positively to, and even lead, the interdisciplinary ongoing care of AD patients. For example, the caregiver can help with memory aids, behavioral interventions, the maintenance of exercise and nutrition, healthcare proxies and housing arrangements, decisions about intensity of treatment, and the timely implementation of palliative care approaches. Caregivers skilled in such matters will increase the quality of life of the AD patient and reduce their dependency. Many support services and educational activities are known to help caregivers and their patients, yet their availability is variable, and it is unclear whose responsibility it is to organize and finance them.

Entities:  

Mesh:

Year:  1999        PMID: 10622676

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  3 in total

1.  The Role of Caregivers in the Management of Alzheimer's disease: Examples from Asian Countries.

Authors:  Joydeep D Chaudhuri; Srijit Das
Journal:  Sultan Qaboos Univ Med J       Date:  2006-12

Review 2.  Dementia and its implications for public health.

Authors:  Daniel P Chapman; Sheree Marshall Williams; Tara W Strine; Robert F Anda; Margaret J Moore
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

Review 3.  Barriers and enablers in the use of respite interventions by caregivers of people with dementia: an integrative review.

Authors:  Marie-Conception Leocadie; Marie-Hélène Roy; Monique Rothan-Tondeur
Journal:  Arch Public Health       Date:  2018-11-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.